NCT00203463View on ClinicalTrials.gov

Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
PTSD
Interventions
DRUG

topiramate

Trial Locations (1)

35404

Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa

All Listed Sponsors
collaborator

Ortho-McNeil Janssen Scientific Affairs, LLC

INDUSTRY

lead

Tuscaloosa Research & Education Advancement Corporation

OTHER

NCT00203463 - Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter